4//SEC Filing
Lin Celia 4
Accession 0001209191-23-010510
CIK 0001831828other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:08 PM ET
Size
5.4 KB
Accession
0001209191-23-010510
Insider Transaction Report
Form 4
Lin Celia
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-15+100,000→ 100,000 totalExercise: $7.87Exp: 2033-02-14→ Class A Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001859386
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:08 PM ET
- Size
- 5.4 KB